pravastatin has been researched along with Fibroma, Shope in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, D; Chandraker, A; Gabardi, S; Kim, M; Klasek, R; Mackenzie, MR; Ramasamy, S; Tan, CS | 1 |
| Moriyama, T; Sorokin, A | 1 |
2 other study(ies) available for pravastatin and Fibroma, Shope
| Article | Year |
|---|---|
Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Topics: Adult; Aged; BK Virus; Disease Progression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Polyomavirus Infections; Postoperative Complications; Pravastatin; Treatment Outcome; Tumor Virus Infections; Viremia | 2015 |
Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.
Topics: BK Virus; Caveolin 1; Epithelial Cells; Humans; Kidney Tubules, Proximal; Polyomavirus Infections; Pravastatin; Tumor Virus Infections | 2008 |